NCT00502567 2011-07-27
A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors
AstraZeneca
Phase 1 Completed
Clinical Trials
3 trialsNCT00501605 2011-01-21
Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases
AstraZeneca
Phase 1 Completed
NCT00503477 2009-06-12
A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan
AstraZeneca
Phase 1 Completed